Sinopharm Group Co. Ltd.

HK$17.16As of Sun 8 Nov 2026, 12:00 UTC
HKEX:1099Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (4.33%)
Div yield 4.69%
ROE 7.97%
Medical Distribution
Beta (5Y) 0.43
PE TTM 6.406
TSR TTM (6.90%)
Mkt cap HK$53.55B
ROIC 6.88%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$17
(3.19%)
3.60%
Hold 1|12|10|9|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.37
0.41
0.46
0.50
22.59%
25.72%
32.80%
36.34%
Revenue¥B
5.524
5.605
5.615
5.465
7.43%
10.27%
10.22%
3.20%
Peers (US$6.831B)
Cap (US$)
PE
5.466B
28.06x
Capital
TTM
5Y
10Y
Leveragex
1.510
0.988
0.910
EBIT/Intx
1.437
0.146
0.115
Own earn%
252.55
(107.00)
(93.19)
Sh yield%
48.34
32.00
34.41
Owners
Insiders/Inst%
2.57
21.05
Short interest%
1.76
SBC / revenue%
5.89
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
15–24
$1 testx
0.0
Incr. ROIC%
3